Lipids, Blood Pressure, Kidney-what was New in 2012?

被引:9
作者
Banach, Maciej [1 ]
Hering, Dagmara [2 ]
Narkiewicz, Krzysztof [2 ]
Mysliwiec, Michal [3 ]
Rysz, Jacek [4 ]
Malyszko, Jolanta [3 ]
机构
[1] Med Univ Lodz, Dept Hypertens, Chair Nephrol & Hypertens, PL-90549 Lodz, Poland
[2] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland
[3] Med Univ, Dept Nephrol & Transplantol, Bialystok, Poland
[4] Med Univ Lodz, Chair Nephrol & Hypertens, Dept Nephrol Hypertens & Family Med, PL-90549 Lodz, Poland
关键词
Hypertension; kidney disease; lipid disorders; new data; trials; DENSITY-LIPOPROTEIN CHOLESTEROL; SUBTILISIN/KEXIN TYPE 9; CORONARY-HEART-DISEASE; RENAL SYMPATHETIC DENERVATION; HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; DAILY ORAL CYCLOPHOSPHAMIDE; RENIN-ANGIOTENSIN SYSTEM; TYPE-2; DIABETIC-PATIENTS; MONOCLONAL-ANTIBODY; HYPERTENSIVE PATIENTS;
D O I
10.3923/ijp.2012.659.678
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The year 2012 has been extremely interesting concerning new findings on diagnosis, management and therapy of dyslipidaemia, hypertension and kidney disease. Looking at recent lipid disorders studies, two issues have seemed to be especially important-searching for new potent biomarkers of lipid disorders (including studies on dysfunctional High Density Lipoprotein [HDL] cholesterol, as well as subfractions/subpopulations of HDL/Low Density Lipoprotein [LDL] cholesterol) and research on new lipid disorders drugs, especially concerning proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, which seem to be very potent in LDL-C lowering. Within the past year, there has been also growing clinical and research progress in hypertension management, especially concerning Resistant Hypertension (RH). In 2012, many important studies on Renal denervation (RDN), as a method of RH therapy have been published, including the ones with patients with different concomitant diseases (e.g., Chronic Kidney Disease (CKD)), as well as with longer follow-up. On the basis of the available data RDN has gained an important role in RH treatment and has recently been introduced to clinical practice. November 2012 has been critical for new nephrology data, as the most important trails were presented during American Society of Nephrology (ASN) Congress in San Diego. They concerned among others, the problems of secondary hyperparathyroidism management in CKD patients, new data on transplantations (e.g., glucocorticoid avoidance strategy), nephro cardiology (stepped pharmacotherapy algorithm vs. ultrafiltration in heart failure patients with CKD), as well as acute kidney injury and diabetic nephropathy (new data on bardoxolone methyl).
引用
收藏
页码:659 / 678
页数:20
相关论文
共 162 条
[141]   Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: Preliminary results [J].
Stepien, Mariusz ;
Rosniak-Bak, Kinga ;
Paradowski, Marek ;
Misztal, Malgorzata ;
Kujawski, Krzysztof ;
Banach, Maciej ;
Rysz, Jacek .
MEDICAL SCIENCE MONITOR, 2011, 17 (11) :PR13-PR18
[142]   Role and significance of statins in the treatment of hypertensive patients [J].
Stepien, Mariusz ;
Banach, Maciej ;
Mikhailidis, Dimitri P. ;
Gluba, Anna ;
Kjeldsen, Sverre E. ;
Rysz, Jacek .
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (08) :1995-2005
[143]   Association of kidney disease measures with poor outcomes [J].
Stevens, Paul E. ;
Farmer, Christopher K. .
LANCET, 2012, 380 (9854) :1628-1630
[144]   Association between atherosclerosis and osteoporosis, the role of vitamin D [J].
Stojanovic, Olivera Llic ;
Lazovic, Milica ;
Lazovic, Marko ;
Vuceljic, Marina .
ARCHIVES OF MEDICAL SCIENCE, 2011, 7 (02) :179-188
[145]   Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients The GAUSS Randomized Trial [J].
Sullivan, David ;
Olsson, Anders G. ;
Scott, Rob ;
Kim, Jae B. ;
Xue, Allen ;
Gebski, Val ;
Wasserman, Scott M. ;
Stein, Evan A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (23) :2497-2506
[146]   Potential Effects of Aggressive Decongestion During the Treatment of Decompensated Heart Failure on Renal Function and Survival [J].
Testani, Jeffrey M. ;
Chen, Jennifer ;
McCauley, Brian D. ;
Kimmel, Stephen E. ;
Shannon, Richard P. .
CIRCULATION, 2010, 122 (03) :265-272
[147]   Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease [J].
Torres, Vicente E. ;
Chapman, Arlene B. ;
Devuyst, Olivier ;
Gansevoort, Ron T. ;
Grantham, Jared J. ;
Higashihara, Eiji ;
Perrone, Ronald D. ;
Krasa, Holly B. ;
Ouyang, John ;
Czerwiec, Frank S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25) :2407-2418
[148]  
United States Renal Data System (USRDS), 2012, ANN DAT REP ATL CHRO
[149]   Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians [J].
van der Steeg, Wim A. ;
Hovingh, G. Kees ;
Klerkx, Anke H. E. M. ;
Hutten, Barbara A. ;
Nootenboom, Inge C. ;
Levels, Johannes H. M. ;
van Tol, Arie ;
Dallinga-Thie, Gees M. ;
Zwinderman, Aeilko H. ;
Kastelein, John J. P. ;
Kuivenhoven, Jan Albert .
JOURNAL OF LIPID RESEARCH, 2007, 48 (03) :674-682
[150]   Eculizumab for the Treatment of Dense-Deposit Disease [J].
Vivarelli, Marina ;
Pasini, Andrea ;
Emma, Francesco .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (12) :1163-1165